Regeneron Pharmaceuticals | Kapitał Własny I Rezerwy



Equity Capital And Reserves Zmiana Data
AbbVie USD 3.32B 2.71B 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Astellas Pharma JPY 1.51T 19.45B 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
J&J USD 78.11B 6.62B 2025-03
Kyowa Hakko Kirin JPY 831.42B 19.39B 2025-03
Merck USD 46.31B 1.81B 2024-12
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Teva Pharmaceutical Industries USD 5.72B 344M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
United Therapeutics USD 6.81B 363.2M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Regeneron Pharmaceuticals Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.